Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Generation of fibrinolytic activity by infusion of activated protein C into dogs.
P C Comp, C T Esmon
P C Comp, C T Esmon
Published November 1, 1981
Citation Information: J Clin Invest. 1981;68(5):1221-1228. https://doi.org/10.1172/JCI110368.
View: Text | PDF
Research Article Article has an altmetric score of 9

Generation of fibrinolytic activity by infusion of activated protein C into dogs.

  • Text
  • PDF
Abstract

Bovine-activated protein C, administered intravenously to dogs, increases the rate of lysis of whole blood clots. Protein C, bovine prothrombin, and diisopropylfluorophosphate-inactivated protein Ca do not increase the rate of lysis. Repeated infusions of protein Ca sustain rapid blood clot lysis, but neither elevate circulating fibrin-split products nor decrease circulating plasminogen levels. The administration of protein Ca results in the elevation of the levels of lysine-adsorbable plasminogen activator activity in the plasma. When partially purified concentrates of this activator are added to normal dog blood at the levels seen following protein Ca injection, the rate of clot lysis is similar to that seen after protein Ca injection. The addition of protein Ca to citrated whole blood in vitro, with the subsequent neutralization of protein Ca with antibodies, results in increased rates of lysis when plasma made from the treated blood is reinjected into the animal. The generation of fibrinolytic activity is dependent on both cellular and plasma components of blood. A model of protein Ca fibrinolytic activity has a minimum of two components: a secondary messenger formed by protein Ca action on blood cells and plasma, and the subsequent appearance of plasminogen activator in the animal in response to that messenger.

Authors

P C Comp, C T Esmon

×

Total citations by year

Year: 2016 2015 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 1968 Total
Citations: 1 2 2 4 4 2 7 1 2 1 1 4 1 3 3 3 2 2 6 2 6 5 10 9 7 16 19 21 14 13 26 13 6 1 219
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (220)

Title and authors Publication Year
Trauma Induced Coagulopathy
E Gonzalez, HB Moore, EE Moore
2016
Intraperitoneal administration of activated protein C prevents postsurgical adhesion band formation
P Dinarvand, SM Hassanian, H Weiler, AR Rezaie
Blood 2015
Biofluid Mechanics
DA Rubenstein, W Yin, MD Frame
Biofluid Mechanics 2015
Handbook of Proteolytic Enzymes
FS Markland, S Swenson
Handbook of Proteolytic Enzymes 2013
Oxygen Transport to Tissue XXXV
SV Huffel, G Naulaers, A Caicedo, DF Bruley, DK Harrison
2013
Oxygen Transport to Tissue XXXIV
WJ Welch, F Palm, DF Bruley, DK Harrison
2012
Oxygen Transport to Tissue XXXIV
WJ Welch, F Palm, DF Bruley, DK Harrison
2012
Oxygen Transport to Tissue XXXIV
WJ Welch, F Palm, DF Bruley, DK Harrison
2012
Oxygen Transport to Tissue XXXIV
WJ Welch, F Palm, DF Bruley, DK Harrison
2012
Critical Care Obstetrics
WE Scorza, A Scardella
Critical Care Obstetrics 2011
Critical Care Obstetrics: Belfort/Critical Care Obstetrics
D Dizon-Townson
Critical Care Obstetrics: Belfort/Critical Care Obstetrics 2011
Oxygen Transport to Tissue XXXII
JC LaManna, MA Puchowicz, K Xu, DK Harrison, DF Bruley
2011
Oxygen Transport to Tissue XXXII
JC LaManna, MA Puchowicz, K Xu, DK Harrison, DF Bruley
2011
Regulation of the protein C anticoagulant and antiinflammatory pathways
AR Rezaie
Current medicinal chemistry 2010
Vitamins & Hormones
KJ Hare, FK Knop
Vitamins & Hormones 2010
Oxygen Transport to Tissue XXXI
E Takahashi, DF Bruley
2009
Oxygen Transport to Tissue XXXI
E Takahashi, DF Bruley
2009
Oxygen Transport to Tissue XXXI
E Takahashi, DF Bruley
2009
Oxygen Transport to Tissue XXXI
E Takahashi, DF Bruley
2009
Oxygen Transport to Tissue XXXI
E Takahashi, DF Bruley
2009
Oxygen Transport to Tissue XXXI
E Takahashi, DF Bruley
2009
Post‐translational Modification of Protein Biopharmaceuticals
G Walsh
2009
Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells
JS Bae, L Yang, AR Rezaie
Journal of Thrombosis and Haemostasis 2008
Negative pressure dressing for promoting wound healing of purpura fulminans in a newborn with homozygous protein C deficiency
A Chuansumrit, N Kanogsunthornrat, N Sirachainan, S Porapakpenjun, R Chantarukha, S Warrasak, P Wongwerawattanakoon
Blood Coagulation & Fibrinolysis 2007
Negative pressure dressing for promoting wound healing of purpura fulminans in a newborn with homozygous protein C deficiency:
A Chuansumrit, N Kanogsunthornrat, N Sirachainan, S Porapakpenjun, R Chantarukha, S Warrasak, P Wongwerawattanakoon
Blood Coagulation & Fibrinolysis 2007
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)
RM Bertina, NH van Tilburg, F Haverkate
Journal of Thrombosis and Haemostasis 2006
Cardiopulmonary bypass in patients with pre-existing coagulopathy
William DeBois, Junli Liu, Leonard Lee, Leonard Girardi, Wilson Ko, Anthony Tortolani, Karl Krieger, O Wayne Isom
The Journal of Extra-Corporeal Technology 2005
Platelet factor 4 modulation of the thrombomodulin–protein C system
A Slungaard
Critical Care Medicine 2004
Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats
IG Schoots, M Levi, AK van Vliet, AM Maas, EH Roossink, TM van Gulik
Critical Care Medicine 2004
Platelet factor 4 modulation of the thrombomodulin–protein C system:
A Slungaard
Critical Care Medicine 2004
Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats:
IG Schoots, M Levi, AK van Vliet, AM Maas, EH Roossink, TM van Gulik
Critical Care Medicine 2004
Platelet factor 4 enhances generation of activated protein C in vitro and in vivo
A Slungaard, JA Fernandez, JH Griffin, NS Key, JR Long, DJ Piegors, SR Lentz
Blood 2003
Activated protein C: Potential therapy for severe sepsis, thrombosis, and stroke
JH Griffin, B Zlokovic, JA Fernández
Seminars in Hematology 2002
Management of patients with severe sepsis, treated by drotrecogin alfa (activated)
PF Laterre, D Heiselman
The American Journal of Surgery 2002
Chelator, metal ion and buffer studies for protein C separation
H Wu, DF Bruley
Comparative Biochemistry and Physiology - Part A Molecular & Integrative Physiology 2002
Vascular Dysfunction in Hyperhomocyst(e)inemia. Implications for Atherothrombotic Disease
O Stanger, M Weger, W Renner, R Konetschny
Clinical Chemistry and Laboratory Medicine 2001
Protein C Replacement in Severe Meningococcemia: Rationale and Clinical Experience
L Alberio, B Lammle, CT Esmon
Clinical Infectious Diseases 2001
Vitronectin Functions as a Cofactor for Rapid Inhibition of Activated Protein C by Plasminogen Activator Inhibitor-1: IMPLICATIONS FOR THE MECHANISM OF PROFIBRINOLYTIC ACTION OF ACTIVATED PROTEIN C
AR Rezaie
The Journal of biological chemistry 2001
Modeling zymogen protein C
L Perera, C Foley, TA Darden, D Stafford, T Mather, CT Esmon, LG Pedersen
Biophysical Journal 2000
Activated protein C prevents multiple organ injury following extensive hepatectomy in cirrhotic rats
A Yoshikawa, T Kaido, S Seto, Y Katsuura, M Imamura
Journal of Hepatology 2000
Modeling Zymogen Protein C
L Perera, C Foley, TA Darden, D Stafford, T Mather, CT Esmon, LG Pedersen
Biophysical Journal 2000
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation
P Gresele, S Momi, M Berrettini, GG Nenci, HP Schwarz, N Semeraro, M Colucci
Journal of Clinical Investigation 1998
Protein C Anticoagulant System in Patients with Interstitial Lung Disease
H Kobayashi, EC Gabazza, O Taguchi, H Wada, H Takeya, J Nishioka, H Yasui, T Kobayashi, O Hataji, K Suzuki, Y Adachi
American journal of respiratory and critical care medicine 1998
Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis
PA von Borne, L Bajzar, JC Meijers, ME Nesheim, BN Bouma
Journal of Clinical Investigation 1997
Atherosclerosis
EM MD, ST MD, EA MD, AW MD, ED MD
The Annals of Thoracic Surgery 1997
The 2.8 A crystal structure of Gla-domainless activated protein C
T Mather, V Oganessyan, P Hof, R Huber, S Foundling, C Esmon, W Bode
The EMBO Journal 1996
Morphological and hemostatic changes in rats with abdominal arterial prosthesis
E Chabielska, V Kolpakov, MC D'Adamo, AD Curtis, W Buczko, L Iacoviello, MB Donati
Thrombosis Research 1996
Coronary artery bypass graft surgery in a patient with hereditary protein S deficiency
HP Grocott, F Clements, K Landolfo
Journal of Cardiothoracic and Vascular Anesthesia 1996
25. Hämophilie-Symposion Hamburg 1994
I Scharrer, W Schramm
1996
Angiology in Practice
AM Salmasi, A Strano
1996
Purpura fulminans in severe congenital protein C deficiency: Monitoring of treatment with protein C concentrate
, W Ehrenthal, G Hafner, D Schranz
European Journal of Pediatrics 1996
Human protein C and activated protein C
FJ Castellino
Trends in Cardiovascular Medicine 1995
Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor
L Bajzar, R Manuel, ME Nesheim
The Journal of biological chemistry 1995
A comparative study of partial primary structures of the catalytic region of mammalian protein C
M Murakawa, T Okamura, T Kamura, M Kuroiwa, M Harada, Y Niho
British Journal of Haematology 1994
Plasma protein c activity is enhanced by arsenic but inhibited by fluorescent humic acid associated with blackfoot disease
HL Yang, SC Tu, FJ Lu, HC Chiu
American Journal of Hematology 1994
Genetic analysis of a large kindred exhibiting type I protein C deficiency and associated thrombosis
JA Tomczak, RA Ando, HG Sobel, EG Bovill, GL Long
Thrombosis Research 1994
Construction, Expression, and Properties of a Recombinant Chimeric Human Protein C with Replacement of Its Growth Factor-like Domains by Those of Human Coagulation Factor IX
S Yu, L Zhang, A Jhingan, WT Christiansen, FJ Castellino
Biochemistry 1994
Properties of Recombinant Chimeric Human Protein C and Activated Protein C Containing the .gamma.-Carboxyglutamic Acid and Trailing Helical Stack Domains of Protein C Replaced by Those of Human Coagulation Factor IX
WT Christiansen, FJ Castellino
Biochemistry 1994
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg
1994
Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates
SR Hanson, JH Griffin, LA Harker, AB Kelly, CT Esmon, A Gruber
Journal of Clinical Investigation 1993
Protein C activator from the venom of Agkistrodon blomhoffi ussuriensis retards thrombus formation in the arterio-venous shunt in rats
AE Kogan, GV Bashkov, ID Bobruskin, EP Romanova, VA Makarov, SM Strukova
Thrombosis Research 1993
Neutralization of plasminogen activator inhibitor-1 (PAI-1) by activated protein C is species-dependent
P Grailhe, A Bezeaud, P Gaussem, MC Guillin, E Anglés-Cano
Fibrinolysis 1993
Shock, Sepsis, and Organ Failure
G Schlag, H Redl, D Traber
1993
The effect of activated protein C on fibrinolysis in cell-free plasma can be attributed specifically to attenuation of prothrombin activation
L Bajzar, M Nesheim
The Journal of biological chemistry 1993
Effect of matrices on affinity purification of protein C
K Kang, D Ryu, WN Drohan, CL Orthner
Biotechnology and Bioengineering 1992
Protein C, protein S and C4b-binding protein in neonatal severe infection and septic shock
J Román, F Velasco, F Fernandez, M Fernandez, R Villalba, V Rubio, A Torres
Journal of Perinatal Medicine 1992
Blockade of protein C activation reduces microvascular surgical blood loss
RA Squires, S Smith, LR Pennington, PC Comp
Journal of Surgical Research 1992
Biological risk factors for sudden death in patients with coronary artery disease and without heart failure
P Lauribe, D Benchimol, JF Dartigues, S Dada, H Benchimol, F Drouillet, J Bonnet, H Bricaud
International Journal of Cardiology 1992
Purpura fulminans méningococcique : Particularités physiopathologiques
F Thomas, Y Ravaud
Réanimation Urgences 1992
Pharmacological modulation of fibrinolysis by antithrombotic and cardiovascular drugs
J Fareed, P Bacher, HL Messmore, JM Walenga, DA Hoppensteadt, A Strano, R Pifarre
Progress in Cardiovascular Diseases 1992
Enhancing protein C interaction with thrombin results in a clot-activated anticoagulant
MA Richardson, B Gerlitz, BW Grinnell
Nature 1992
Cardiovascular Biomaterials
GW Hastings
1992
Influence of specific gamma-carboxyglutamic acid residues on the integrity of the calcium-dependent conformation of human protein C
L Zhang, FJ Castellino
The Journal of biological chemistry 1992
Acquired protein S deficiency
B Kemkes-Matthes
The Clinical Investigator 1992
The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system
M Hessing
Biochemical Journal 1991
Species specificity of the fibrinolytic effects of activated protein C
RE Weinstein, FJ Walker
Thrombosis Research 1991
Proteins C and S in patients with advanced prostatic cancer
PD Oliveira, MG Oliveira, F Pina, JA Andrade, JM Pina-Cabral
Thrombosis Research 1991
The role of fibrinolytic factors in ischaemia
M Pandolfi, A Al-Rushood
Eye 1991
The role of the endothelium in in vivo anticoagulation
GT Housholder
Journal of Oral and Maxillofacial Surgery 1991
Activated protein C: Antithrombotic properties and influence on fibrinolysis in an animal model
J Römisch, KH Diehl, G Reiner, EP Paques
Fibrinolysis 1991
Recombinant Technology in Hemostasis and Thrombosis
LW Hoyer, WN Drohan
1991
Deep Venous Thrombosis and Pulmonary Embolism in Pregnancy
SE Rutherford, JP Phelan
Obstetrics and Gynecology Clinics of North America 1991
Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin
BW Grinnell, JD Walls, B Gerlitz
The Journal of biological chemistry 1991
Enhancement of rabbit protein S anticoagulant cofactor activity in vivo by modulation of the protein S C4B binding protein interaction
RE Weinstein, FJ Walker
Journal of Clinical Investigation 1990
Low doses of activated protein C delay arterial thrombosis in rats
MD Smirnov, MV Pyzh, DV Borovikov, AN Atorozhilova, AB Dobrovolsky, VL Golubych, NA Gratsiansky
Thrombosis Research 1990
Effects of acetylthrombin on protein C activation and fibrinogen clotting
K Nakagomi, K Ajisaka, I Yokota
Thrombosis Research 1990
Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis
A Gruber, SR Hanson, AB Kelly, BS Yan, N Bang, JH Griffin, LA Harker
Circulation 1990
Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis
CY Liu, S Chien
1990
The Endothelial Cytoskeleton: Organization in Normal and Regenerating Endothelium*
AI Gotlieb
Toxicologic pathology 1990
The activated protein C-mediated enhancement of tissue-type plasminogen activator-induced fibrinolysis in a cell-free system
L Bajzár, JC Fredenburgh, M Nesheim
The Journal of biological chemistry 1990
Congenital severe protein C deficiency in adults
E Melissari, VV Kakkar
British Journal of Haematology 1989
Protein C Activity and Antigen in Premature and Fullterm Newborn Infants
R Bennhagen, L Holmberg
Acta Paediatrica 1989
Generation of anticoagulant and fibrinolytic activity of blood after intravenous injection of protein Ca into rats
AE Kogan, SM Strukova
Bulletin of Experimental Biology and Medicine 1989
Fibrinogenolysis in thrombotic thrombocytopenic purpura
E Kakishita, T Koyama, M Higuchi, O Kunitomi, Y Oura, K Nagai
American Journal of Hematology 1989
Rapid homogeneous enzyme immunoassay of plasma protein C
K Suzuki, T Hayashi, M Koyama, T Yoshimura, M Shimamoto, N Kimura, M Kita
Clinica Chimica Acta 1989
Purification and characterization of plasma protein C inhibitor
F España, M Berrettini, JH Griffin
Thrombosis Research 1989
Protein C : Rouen, a new hereditary protein C abnormality with low anticoagulant but normal amidolytic activities
M Vasse, JY Borg, M Monconduit
Thrombosis Research 1989
Protein C assays in uremia
PJ Sørensen, F Knudsen, AH Nielsen, J Dyerberg
Thrombosis Research 1989
10 Protein C and protein S
G Dolan, J Ball, FE Preston
Baillière's Clinical Haematology 1989
Hemostasis in liver transplantation
RJ Porte, EA Knot, FA Bontempo
Gastroenterology 1989
Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C
WP Fay, WG Owen
Biochemistry 1989
Increased tissue-plasminogen activator (t-PA) levels in patients under oral anticoagulant therapy
J Grulich-Henn, K Loechelt, W Speiser, G Mller-Berghaus
Blut Zeitschrift für die Gesamte Blutforschung 1989
The Last Three Consecutive Epidermal Growth Factor-like Structures of Human Thrombomodulin Comprise the Minimum Functional Domain for Protein C-activating Cofactor Activity and Anticoagulant Activity
M Zushi, K Gomi, S Yamamoto, I Maruyama, T Hayashi, K Suzuki
The Journal of biological chemistry 1989
Conformational changes in an epitope localized to the NH2-terminal region of protein C
CL Orthner, RD Madurawe, WH Velander, WN Drohan, FD Battey, DK Strickland
The Journal of biological chemistry 1989
Characterization of a synthetic peptide that inhibits the interaction between protein S and C4b-binding protein
FJ Walker
The Journal of biological chemistry 1989
Tissue-Type Plasminogen Activator: A Review of its Pharmacology and Therapeutic Use as a Thrombolytic Agent
D Collen, HR Lijnen, PA Todd, KL Goa
Drugs 1989
Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor
JA Koedam, JC Meijers, JJ Sixma, BN Bouma
Journal of Clinical Investigation 1988
Heparin Cofactor II, Antithrombin and Protein C in Plasma from Term and Preterm Infants
TR Andersson, H Bangstad, ML Larsen
Acta Paediatrica 1988
A combination of factor Xa and phosphatidylcholine-phosphatidylserine vesicles bypasses factor VIII in vivo
AR Giles, KG Mann, ME Nesheim
British Journal of Haematology 1988
Protein C in Acute Renal Failure
PJ Sørensen, F Knudsen, AH Nielsen, J Dyerberg
Acta Medica Scandinavica 1988
Immunological and functional determination of the protease inhibitors, protein C and antithrombin III, in liver cirrhosis and in neoplasia
KH Zurborn, W Kirch, HD Bruhn
Thrombosis Research 1988
Immunoblotting studies of the molecular forms of protein C in plasma
MJ Heeb, HP Schwarz, T White, B Lämmle, M Berrettini, JH Griffin
Thrombosis Research 1988
Immunoradiometric assays for the Ca(II)-dependent and Ca(II)-independent conformation of human protein C
SR Poort, PP Deutz-Terlouw, A Wijngaarden, RM Bertina
Thrombosis Research 1988
The dermatologist and protein C
SJ Miller
Journal of the American Academy of Dermatology 1988
The role of protein C in congenital and acquired thrombotic disorders
GT Housholder
Journal of Oral and Maxillofacial Surgery 1988
Effect of activated protein c on the fibrinolytic components released by cultured bovine aortic endothelial cells
Y Sakata, JH Griffin, DJ Loskutoff
Fibrinolysis 1988
Protein C inhibitor/plasminogen activator inhibitor 3
M Geiger
Fibrinolysis 1988
Hemostatic Abnormalities in Nephrotic Syndrome
R Abdullah
Veterinary Clinics of North America Small Animal Practice 1988
Haemostatic Aspects of Renal Transplantation
PJ Sørensen, EB Schmidt, F Knudsen, AH Nielsen, SD Kristensen, J Dyerberg, HJ Kornerup
Scandinavian Journal of Urology and Nephrology 1988
Genital Necrosis Secondary to Warfarin Therapy
RJ Kandrotas, J Deterding
Nature Communications 1988
Protein C in acute stroke
A D'Angelo, G Landi, S Vigano'D'Angelo, EN Orazio, E Boccardi, L Candelise, PM Mannucci
Stroke; a journal of cerebral circulation 1988
Endothelial Cell Biology in Health and Disease
N Simionescu, M Simionescu
1988
Vascular Endothelium in Health and Disease
S Chien
1988
Biotechnology in blood transfusion
CT Sibinga, PC Das, LR Overby
1988
Calcium binding to the epidermal growth factor homology region of bovine protein C
AK Ohlin, S Linse, J Stenflo
The Journal of biological chemistry 1988
Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro
KL Moore, SP Andreoli, NL Esmon, CT Esmon, NU Bang
Journal of Clinical Investigation 1987
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon
FB Taylor, A Chang, CT Esmon, A D'Angelo, S Vigano-D'Angelo, KE Blick
Journal of Clinical Investigation 1987
Die immunologische und funktionelle Protein C-Bestimmung bei verschiedenen internistischen Erkrankungen
KH Zurborn, H Broers, W Kirch, N Jäger, HD Bruhn
Klinische Wochenschrift 1987
Thrombogenic and Nonthromboge0nic Biological Surfaces
JF Mustard, HM Groves, RL Kinlough-Rathbone, MA Packham
Annals of the New York Academy of Sciences 1987
Trans–Activated Expression of Fully Gamma–Carboxylated Recombinant Human Protein C, an Antithrombotic Factor
BW Grinnell, DT Berg, J Walls, SB Yan
Bio/Technology 1987
Clinical Implications of the Protein C/Protein S System
PC Comp
Annals of the New York Academy of Sciences 1987
Enhanced fibrinolysis caused by tissue plasminogen activator release in hemodialysis
W Speiser, J Wojta, C Korninger, JC Zazgornik, BR Binder
Kidney International 1987
Biochemical and functional properties of protein C and protein S
DK Strickland, CM Kessler
Clinica Chimica Acta 1987
Thrombosis in inherited deficiencies of antithrombin, protein C, and protein S
RD Rosenberg, KA Bauer
Human Pathology 1987
Protein C functional assay using snake venom activator
IV Nathan, H Ping, MM Pradhan
Thrombosis Research 1987
Oral contraceptives reduce total protein S, but not free protein S
IA Huisveld, JE Hospers, JC Meijers, AE Starkenburg, WB Erich, BN Bouma
Thrombosis Research 1987
Human protein c induces anticoagulation and increased fibrinolytic activity in the cat
MD Burdick, RG Schaub
Thrombosis Research 1987
Characterization of the protein C activator protac® from the venom of the southern copperhead (Agkistrodon contortrix) snake
K Stocker, H Fischera, J Meier, M Brogli, L Svendsen
Toxicon 1987
The effect of stanozolol on various types of defective fibrinolysis
L Tengborn
Fibrinolysis 1987
The New Dimensions of Warfarin Prophylaxis
S Wessler, CG Becker, Y Nemerson
1987
New Trends in Diagnosis and Management of Stroke
K Poeck, EB Ringelstein, W Hacke
1987
16. Hämophilie-Symposion
G Landbeck, R Marx
1987
The protein C system in patients undergoing cardiopulmonary bypass
PN Knöbl, P Zilla, R Fasol, MM Müller, TC Vukovich
The Journal of Thoracic and Cardiovascular Surgery 1987
Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3
MJ Heeb, F España, M Geiger, D Collen, DC Stump, JH Griffin
The Journal of biological chemistry 1987
Topographical relationships between the monovalent and divalent cation binding sites of des-1-41-light chain bovine plasma protein C and des-1-41-light chain-activated bovine plasma protein C
KA Hill, FJ Castellino
The Journal of biological chemistry 1987
Calcium-dependent interaction between the epidermal growth factor precursor-like region of human protein C and a monoclonal antibody
AK Ohlin, J Stenflo
The Journal of biological chemistry 1987
Congenital thrombotic disorders
GM Rodgers, MA Shuman
American Journal of Hematology 1986
Fibrinolytic system of cultured endothelial cells: Regulation by plasminogen activator inhibitor
DJ Loskutoff, T Ny, M Sawdey, D Lawrence
Journal of Cellular Biochemistry 1986
Low protein C in the neonatal period
M Karpatkin, PM Mannucci, M Bhogal, S Vigano, M Nardi
British Journal of Haematology 1986
Clinical relevance of protein C
I Pabinger
Blut 1986
Lack of pathogenetic role of proteins C and S in thrombosis associated with asparaginase-prednisone-vincristine therapy for leukaemia
CH Pui, CM Chesney, PW Bergum, CW Jackson, SI Rapaport
British Journal of Haematology 1986
Assay of protein c in human plasma: Comparison of amidolytic, coagulation, and immunochemical assays
F Espana, A Estellés, J Aznar, J Gilabert
Thrombosis Research 1986
Fibrinolytic study in a homozygous protein C deficient patient
J Aznar, A Dasi, F España, A Estellés
Thrombosis Research 1986
The Regulation of Hemostasis: The Protein C System
LH Clouse, PC Comp
New England Journal of Medicine 1986
Thromboembolic Disease in Pregnancy
SE Rutherford, JP Phelan
Clinics in Perinatology 1986
Expression of factor V on human umbilical vein endothelial cells is modulated by cell injury
AE Annamalai, GJ Stewart, B Hansel, M Memoli, HC Chiu, DW Manuel, K Doshi, RW Colman
Arteriosclerosis (Dallas, Tex.) 1986
2. Rundtischgespräch Therapiebedingte Infektionen und Immundefekte bei Hämophilen
G Landbeck, R Marx
1986
8 Advances in Clinical Fibrinolysis
LW Hessel, C Kluft
Clinics in Haematology 1986
5 The Natural Anticoagulants
HH Salem
Clinics in Haematology 1986
Clinical relevance of protein C
I Pabinger
Blut Zeitschrift für die Gesamte Blutforschung 1986
Die Bedeutung des Endothels der Gefäßwand für die Aufrechterhaltung der Hämostase
U Delvos, G Müller-Berghaus
Klinische Wochenschrift 1985
Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity
Y Sakata, S Curriden, D Lawrence, JH Griffin, DJ Loskutoff
Proceedings of the National Academy of Sciences 1985
Aspirin, indomethacin and dazoxiben do not affect the fibrinolytic activation induced by venous occlusion
H Bounameaux, P Gresele, M Hanss, FD Cock, J Vermylen, D Collen
Thrombosis Research 1985
A new function for activated protein C: Activated protein C prevents inhibition of plasminogen activators by releasate from mononuclear leukocytes — platelet suspensions stimulated by phorbol diester
FB Taylor, MS Lockhart
Thrombosis Research 1985
Protein C activity in renal disease
PJ Sørensen, F Knudsen, AH Nielsen, J Dyerberg
Thrombosis Research 1985
Thromboembolism, Coumarin Necrosis, and Protein C
FJ Kazmier
Mayo Clinic Proceedings 1985
Antithrombotic Potential of Pentoxifylline A Hemorheologically Active Drug
RH Schröer
Angiology 1985
Synthesis and secretion of protein C inhibitor by the human hepatoma-derived cell line, Hep G2
F Morito, H Saito, K Suzuki, S Hashimoto
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1985
Protein C antigen in prothrombin complex concentrates: Content, recovery and half life
H Riess, T Binsack, E Hiller
Blut Zeitschrift für die Gesamte Blutforschung 1985
Cerebral haemorrhagic infarction in young patients with hereditary protein C deficiency: evidence for "spontaneous" cerebral venous thrombosis
AR Wintzen, AW Broekmans, RM Bertina, E Briet, PE Briet, A Zecha, GJ Vielvoye, GT Bots
BMJ : British Medical Journal 1985
Aktueller Stand der Thrombolysetherapie
J van de Loo, F Asbeck
1985
The Role of Endothelium in the Homeostatic Balance of Haemostasis
P Nawroth, W Kisiel, D Stern
Clinics in Haematology 1985
Biosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line
DB Wilson, HH Salem, JS Mruk, I Maruyama, PW Majerus
Journal of Clinical Investigation 1984
Natural anticoagulant mechanisms
RD Rosenberg, JS Rosenberg
Journal of Clinical Investigation 1984
Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys
M Colucci, JM Stassen, D Collen
Journal of Clinical Investigation 1984
Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity
RI Levin, PC Harpel, D Weil, TS Chang, DB Rifkin
Journal of Clinical Investigation 1984
Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells
EG Levin, U Marzec, J Anderson, LA Harker
Journal of Clinical Investigation 1984
Studies of Factors V and VIII:C in an animal model of disseminated intravascular coagulation
AR Giles, ME Nesheim, KG Mann
Journal of Clinical Investigation 1984
The fibrinolytic system in man
AP Reiner, WR Bell
Critical Reviews in Oncology/Hematology 1984
Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator
J Stibbe, C Kluft, EJ Brommer, M Gomes, DS de Jong, J Nauta
European Journal of Clinical Investigation 1984
Protein C Mangel — Risikofaktor für venöse Thrombosen
HG Klingemann, AW Broekmans, RM Bertina, R Egbring, EA Loeliger
Klinische Wochenschrift 1984
Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant therapy
S Viganò, PM Mannucci, S Solinas, B Bottasso, G Mariani
British Journal of Haematology 1984
FAMILIAL VENOUS THROMBOEMBOLISM AND INHERITED ABNORMALITIES OF THE BLOOD CLOTTING SYSTEM
AS Callus
Australian and New Zealand Journal of Medicine 1984
The relationship between thrombomodulin expression and cell cycle stages in cultured rabbit endothelial cells
LE Debault, NL Esmon, CT Esmon
Cytometry 1984
Haemostatic effects of stanozolol in elderly medical patients
M Small, JA MacLean, BM McArdle, RM Bertina, GD Lowe, CD Forbes
Thrombosis Research 1984
A new method for the estimation of protein C by ELISA
C Boyer, C Rothschild, M Wolf, J Amiral, D Meyer, MJ Larrieu
Thrombosis Research 1984
Protein C levels in activated and non-activated prothrombin complex concentrates
J Fareed, Z Parvez, HL Messmore, G Mariani, DA Walz
Thrombosis Research 1984
A model for thrombin protection against endotoxin
FB Taylor, A Chan, LB Hinshaw, CT Esmon, LT Archer, BK Beller
Thrombosis Research 1984
Response of Protein C and Protein C inhibitor to warfarin therapy in patient with combined deficiency of factors V and VIII
MM Bern, K Suzuki, K Mann, P Tracy, L Hoyer, W Jensen, M Gallivan, C Arkin, G Davis
Thrombosis Research 1984
The fibrinolytic system in patients with congenital protein C deficiency
J Conard, MH Horellou, AC Teger-Nilsson, RM Bertina, M Samama
Thrombosis Research 1984
Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozolol
C Kluft, RM Bertina, FE Preston, RG Malia, SL Blamey, GD Lowe, CD Forbes
Thrombosis Research 1984
Severe homozygous protein C deficiency
RH Sills, RA Marlar, RR Montgomery, GN Deshpande, JR Humbert
The Journal of Pediatrics 1984
Homozygous Protein C Deficiency Manifested by Massive Venous Thrombosis in the Newborn
U Seligsohn, A Berger, M Abend, L Rubin, D Attias, A Zivelin, SI Rapaport
New England Journal of Medicine 1984
Molecular Bad Actors and Thrombosis
VJ Marder
New England Journal of Medicine 1984
Biology of Endothelial Cells
EA Jaffe
1984
Haemostatic Failure in Liver Disease
P Fondu, O Thijs
1984
INHERITED PROTEIN C DEFICIENCY AND COUMARIN-RESPONSIVE CHRONIC RELAPSING PURPURA FULMINANS IN A NEWBORN INFANT
HE Branson, R Marble, J Katz, JH Griffin
The Lancet 1983
A new type of congenital dysfibrinogenaemia with defective fibrin lysis—Dusard syndrome: possible relation to thrombosis
J Soria, C Soria, JP Caen
British Journal of Haematology 1983
FIBRINOGEN HETEROGENEITY
MW Mosesson
Annals of the New York Academy of Sciences 1983
A functional assay for protein C in human plasma
RB Francis, MJ Patch
Thrombosis Research 1983
Human fibrinogen heterogeneities: Determination of the major aα chain derivatives in blood
DK Galanakis, MW Mosesson
Thrombosis Research 1983
New Comprehensive Biochemistry
S Yamamoto
New Comprehensive Biochemistry 1983
Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand's factor
NW Stead, KA Bauer, TR Kinney, JG Lewis, EE Campbell, MA Shifman, RD Rosenberg, SV Pizzo
The American Journal of Medicine 1983
Activation of protein C in vivo
PC Comp, RM Jacocks, GL Ferrell, CT Esmon
Journal of Clinical Investigation 1982
Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease
WM Canfield, W Kisiel
Journal of Clinical Investigation 1982
DEFICIENCIES OF PROTEIN C, AN INHIBITOR OF BLOOD COAGULATION
PM Mannucci, S Vigano
The Lancet 1982
Cardiopulmonary Bypass in Patients With Pre-existing Coagulopathy
William DeBois, Junli Liu, Leonard Lee, Leonard Girardi, Wilson Ko, Anthony Tortolani, Karl Krieger, O. Wayne Isom
The Journal of Extra-Corporeal Technology
Kinetic mechanism for stimulation by monovalent cations of the amidase activity of the plasma protease bovine activated protein C
SA Steiner, FJ Castellino
Biochemistry 1985
The Role of Natural Coagulation Inhibitors in Hemostasis
JT Brandt
Clinics in Laboratory Medicine 1984
New approaches to thrombolytic therapy
D Collen, HR Lijnen
Arteriosclerosis (Dallas, Tex.) 1984
Contribution of thrombogenic factors to the pathogenesis of atherosclerosis
S Niewiarowski, AK Rao
Progress in Cardiovascular Diseases 1983
The Physiology of Hemostasis
D Ogston
1983
Protein C inhibitor. Purification from human plasma and characterization
K Suzuki, J Nishioka, S Hashimoto
The Journal of biological chemistry 1983
Proteolytic formation and properties of gamma-carboxyglutamic acid-domainless protein C
NL Esmon, LE DeBault, CT Esmon
The Journal of biological chemistry 1983
Inactivation of human coagulation factor V by activated protein C
K Suzuki, J Stenflo, B Dahlbäck, B Teodorsson
The Journal of biological chemistry 1983
Effects of parathyroid hormone and vitamin D on the renal vitamin K-dependent carboxylating system
PI Karl, PA Friedman
The Journal of biological chemistry 1983
Kinetic studies of the role of monovalent cations in the amidolytic activity of activated bovine plasma protein C
SA Steiner, FJ Castellino
Biochemistry 1982
Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation
CT Esmon, NL Esmon, KW Harris
The Journal of biological chemistry 1982
Amino acid sequence of the light chain of bovine protein C
P Fernlund, J Stenflo
The Journal of biological chemistry 1982
Blut und Blutkrankheiten
L Heilmeyer, K Betke, KG von Boroviczény, D Busch, E Grundmann, H Heimpel, G Hoffmann, W Hunstein, W Keiderling, M Matthes, H Merker, W Müller, P Pfannenstiel
1968

← Previous 1 2 3 … 8 9 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 11 patents
11 readers on Mendeley
See more details